$RPRX news
The latest RPRX stock news: headlines, filings, AI summaries and sentiment for $RPRX, updated around the clock.
- Royalty Pharma Poised to Benefit from Revolution Medicines' FDA-Approved Pancreatic Cancer Drug
- Royalty Pharma Reports Strong Q3 2026 Results and Raises Full-Year Guidance
- Royalty Pharma Raises 2026 Portfolio Receipts Guidance Amid Strong Growth
- Royalty Pharma plc - 10-Q Filing
- Royalty Pharma plc - 8-K Filing
- Royalty Pharma Reports Q3 Revenue Growth to $690 Million
- Royalty Pharma Scheduled to Report Q3 2026 Earnings on November 4